Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelomonocytic, Juvenile × Alemtuzumab × 1 year × Clear all

Sponsor

Conditions

Wilms Tumor 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Pseudomyxoma Peritonei 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Melanoma 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Transplantation 1 Digestive System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Burkitt Lymphoma 1 Adenocarcinoma, Clear Cell 1

Interventions

fludarabine 5 Cyclophosphamide 5 Melphalan 4 thymoglobulin 3 fludarabine phosphate 3 Methotrexate 3 blinatumomab 2 Thiotepa 2 Tacrolimus 2 Sirolimus 2 Rituximab 2 Mesna 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 Cytarabine 2 Busulfan 2 Biopsy 2 trametinib 1 omipalisib 1 merphos 1 imetelstat 1 hydrocortisone hemisuccinate 1 Whole-Body Irradiation 1 Vorinostat 1 Transplantation 1 Stem Cell Transplantation 1 Spinal Puncture 1 Specimen Handling 1 Peripheral Blood Stem Cell Transplantation 1 Mycophenolic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡